Medicare Enrolled

Dr. Priyadarshan Bajpayi, M.D.

Child & Adolescent Psychiatry Physician · Massapequa, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5550 MERRICK RD STE 300, Massapequa, NY 11758
6316733233
In practice since 2010 (16 years)
NPI: 1699087148 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bajpayi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bajpayi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bajpayi

Dr. Priyadarshan Bajpayi is a child & adolescent psychiatry physician in Massapequa, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Bajpayi performed 8,659 Medicare services across 1,884 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bajpayi received a total of $217,759 from 43 pharmaceutical and/or device companies across 1742 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bajpayi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 1% volume in NY $217,759 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,659
Medicare services
Top 1% in NY for child & adolescent psychiatry physician
1,884
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~541 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
2,989 $92 $218
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
2,359 $69 $216
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
1,175 $54 $185
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
758 $120 $261
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
304 $172 $325
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
280 $68 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
260 $133 $232
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
215 $164 $399
Psychological test evaluation, first hour
A healthcare professional evaluates the results of psychological testing during an initial one-hour session.
98 $104 $198
Psychotherapy session, 45 min
A 45-minute session of psychotherapy involving talk therapy to address emotional, behavioral, or mental health concerns.
73 $77 $216
Psychotherapy, 30 minutes
A 30-minute session of psychotherapy involving talk therapy to address mental health concerns.
61 $58 $183
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $33 $152
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
42 $12 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$217,759
Total received (2018-2024)
Avg $31,108/year across 7 years
Top 1% in NY for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,742
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$172,430 (79.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24,142 (11.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,187 (9.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$64,660
2023
$66,962
2022
$52,060
2021
$23,333
2020
$5,693
2019
$2,881
2018
$2,169

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alkermes, Inc.
$20,196
Supernus Pharmaceuticals, Inc.
$14,003
Axsome Therapeutics, Inc.
$12,405
Janssen Pharmaceuticals, Inc
$8,677
Otsuka America Pharmaceutical, Inc.
$6,057
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$554
Teva Pharmaceuticals USA, Inc.
$462
ABBVIE INC.
$401
Lundbeck LLC
$372
E.R. Squibb & Sons, L.L.C.
$358
Corium, LLC
$225
Neurocrine Biosciences, Inc.
$174
Vertical Pharmaceuticals, LLC
$132
HARMONY BIOSCIENCES LLC
$106
Indivior Inc.
$99
Tris Pharma Inc
$67
Bausch Health US, LLC
$55
Avion Pharmaceuticals
$52
Takeda Pharmaceuticals U.S.A., Inc.
$49
Braeburn Inc.
$39
Neuronetics, Inc.
$38
Vanda Pharmaceuticals Inc.
$36
Biogen, Inc.
$35
Almatica Pharma LLC
$35
IRONSHORE PHARMACEUTICALS INC.
$18
Neos Therapeutics, LP
$14
Top 3 companies account for 72.1% of 2024 payments
All-time payments by company (2018-2024) ›
Alkermes, Inc.
$78,808
Otsuka America Pharmaceutical, Inc.
$38,597
Axsome Therapeutics, Inc.
$24,142
Janssen Pharmaceuticals, Inc
$18,676
Supernus Pharmaceuticals, Inc.
$14,493
ABBVIE INC.
$12,854
AbbVie Inc.
$7,999
Tris Pharma Inc
$4,271
Lundbeck LLC
$3,639
Takeda Pharmaceuticals U.S.A., Inc.
$1,969
Sunovion Pharmaceuticals Inc.
$1,931
Teva Pharmaceuticals USA, Inc.
$1,434
Ironshore Pharmaceuticals Inc.
$1,129
ITI, Inc.
$1,080
Neos Therapeutics, LP
$950
Bausch Health US, LLC
$648
Corium, LLC
$612
Neurocrine Biosciences, Inc.
$565
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$554
Indivior Inc.
$456
E.R. Squibb & Sons, L.L.C.
$358
Shire North American Group Inc
$312
IDORSIA PHARMACEUTICALS US INC
$283
ARBOR PHARMACEUTICALS, INC.
$279
Allergan, Inc.
$251
Adlon Therapeutics L.P.
$231
Orexo US, Inc.
$227
Almatica Pharma LLC
$179
Vertical Pharmaceuticals, LLC
$132
HARMONY BIOSCIENCES LLC
$106
Avion Pharmaceuticals
$93
Neuronetics, Inc.
$80
Brainsway USA INC
$63
Alfasigma USA, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$56
OWP Pharmaceuticals, Inc.
$47
Braeburn Inc.
$39
Vanda Pharmaceuticals Inc.
$36
Biogen, Inc.
$35
Eisai Inc.
$29
Arbor Pharmaceuticals, Inc.
$27
IRONSHORE PHARMACEUTICALS INC.
$18
Kaleo, Inc.
$11
Top 3 companies account for 65.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adlarity · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BRINTELLIX · BRIXADI · BrainsWay Deep TMS · Brainsway Deep TMS · CAPLYTA · CITALOPRAM · COBENFY · COTEMPLA XR-ODT · Dayvigo · Dhivy · Dyanavel XR · EVZIO · Evekeo · Evekeo ODT · GRALISE · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · MYDAYIS · Methylphenidate Hydrochloride · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · OXTELLAR XR · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · REXULTI · Relexxii · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · Sunosi · TAKHZYRO · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · WAKIX · ZURZUVAE · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in child & adolescent psychiatry physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for child & adolescent psychiatry physician in NY.

Looking for a child & adolescent psychiatry physician in Massapequa?
Compare child & adolescent psychiatry physicians in the Massapequa area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians within 10 mi
148
Per 100K population
10.7
County median income
$143,408
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bajpayi is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bajpayi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bajpayi performed 2,989 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bajpayi receive payments from pharmaceutical companies?
Yes. Dr. Bajpayi received a total of $217,759 from 43 companies across 1,742 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bajpayi's costs compare to other child & adolescent psychiatry physicians in Massapequa?
Dr. Bajpayi's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bajpayi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →